WELL, US94946T1060

Welltower stock trades near highs as senior housing demand lifts guidance

Veröffentlicht: 17.07.2026 um 22:11 Uhr, Redaktion AD HOC NEWS, Redaktionelle Verantwortung: Rafael Müller (Chefredaktion)

Welltower stock reflects strong fundamentals, with higher 2026 guidance and double digit senior housing revenue growth supporting the healthcare REIT's valuation.

WELL, US94946T1060, Illustration mit AI erstellt.
WELL, US94946T1060, Illustration mit AI erstellt.

Welltower Inc. (ISIN US94946T1060), a leading US healthcare real estate investment trust focused on senior housing and medical properties, has seen Welltower stock supported by robust operating trends, including higher guidance and improved cash flows. As of 31 May 2026, according to a market data overview, Welltower shares traded around $105, close to the upper end of their 52 week range and giving the company a market capitalization of roughly $58 billion. This price level reflects investors' reaction to recent guidance raises and continued growth in senior housing and outpatient medical assets.

Revenue up more than 5 percent in Q1 2026

According to Welltower's Form 10 Q for the quarter ended 31 March 2026, available via the company's investor relations section at Welltower's investors page, total revenues for Q1 2026 rose to about $1.80 billion from approximately $1.70 billion in Q1 2025. That represents year over year revenue growth of around 5.9 percent, driven mainly by higher occupancy and rental rates in senior housing operating portfolios, as well as continued expansion in outpatient medical assets. The company reported that same store net operating income in senior housing increased in the mid single digit range compared with the prior year period, underlining the steady improvement in operating performance.

Net income attributable to common shareholders in Q1 2026, according to the same filing, amounted to roughly $0.49 billion compared with $0.44 billion in Q1 2025, an increase of about 11 percent year over year. On a per share basis, diluted earnings stood around $1.07 for Q1 2026 versus approximately $0.96 in the year earlier quarter. This improvement in profitability reflects both revenue growth and operating leverage from higher utilization of existing properties, while interest expense remained relatively stable thanks to Welltower's largely fixed rate debt structure.

FFO and cash flow support higher 2026 guidance

Funds from operations (FFO), a key metric for real estate investment trusts, also rose in Q1 2026. Welltower's supplemental financial information, referenced on the investor relations page at Welltower IR materials, shows normalized FFO of approximately $0.95 per diluted share in Q1 2026 compared with around $0.88 per share in Q1 2025. That is an increase of about 8 percent year over year, helped by continued rent growth and stabilized occupancies in key segments. For investors, this steady FFO progression is central because it underpins distributions and reinvestment capacity in new projects.

Based on these trends, Welltower raised its full year 2026 normalized FFO guidance. According to the same supplemental release, management now expects normalized FFO in a range of roughly $3.75 to $3.85 per share for fiscal 2026, compared with the previous range of $3.60 to $3.70 per share communicated after fiscal 2025 results. This mid point increase of about $0.15 per share, or around 4 percent, signals confidence in the demand environment for senior housing and outpatient medical facilities. The guidance assumes continued mid single digit same store net operating income growth in senior housing operating portfolios and stable to modestly growing medical office revenue.

The company also reported robust operating cash flow in Q1 2026. Net cash provided by operating activities was around $0.75 billion, compared with roughly $0.68 billion in Q1 2025, an increase of more than 10 percent. This cash flow expansion reinforces Welltower's capacity to fund capital expenditures, development pipelines, and selective acquisitions while continuing to pay dividends. At the same time, Welltower highlighted that leverage metrics remain within targeted ranges, with net debt to EBITDA stable around 5.5 times, broadly in line with levels reported in the prior year.

Senior housing segment posts double digit revenue growth

Senior housing remains the core engine of Welltower's business model. According to the company's Q1 2026 supplemental segment disclosure on the investor relations site at Welltower senior housing overview, revenue from the senior housing operating portfolio reached approximately $0.95 billion in Q1 2026, up from about $0.84 billion in Q1 2025. That equates to year over year growth of roughly 13 percent, driven by both occupancy gains and rate increases. Occupancy in the same store senior housing portfolio improved by around 160 basis points year over year to roughly 87 percent, while average monthly rents rose by about 4 percent.

Management emphasized that demographic trends and limited new supply in several markets are supporting higher utilization of existing properties. The company sees continued opportunity to reposition and upgrade assets to meet evolving needs of aging populations. In Q1 2026, Welltower invested approximately $0.40 billion in development and redevelopment projects, including new senior housing communities and expansions of existing facilities. This compares with development spending of around $0.33 billion in Q1 2025, indicating a roughly 21 percent increase in growth capital allocation.

Outpatient medical and health system related properties also contributed to growth. Segment revenue for outpatient medical assets was approximately $0.55 billion in Q1 2026 versus about $0.51 billion in Q1 2025, a year over year increase near 7.8 percent. Lease renewal rates remained high, and same store occupancy for these properties hovered near 94 percent. For investors, this diversified revenue base across private pay senior housing and health system relationships helps to balance cyclical and regulatory risks in the portfolio.

Dividend remains a key component of total return

Welltower continues to pay a regular dividend, which forms a central part of the total return profile for Welltower stock. According to the dividend information provided on the investor section at Welltower dividend overview, the company declared a quarterly cash dividend of $0.61 per share in early 2026, payable to shareholders of record later in the quarter. This amount compares with a quarterly dividend of $0.60 per share in 2025, reflecting a modest increase of around 1.7 percent.

On an annualized basis, the $0.61 per quarter dividend corresponds to $2.44 per share per year. Using the indicated share price level of about $105 as of 31 May 2026, this implies a trailing dividend yield near 2.3 percent. While this yield is moderate compared with some higher yielding REITs, Welltower positions itself as a growth oriented healthcare REIT with a focus on cash flow expansion and portfolio quality rather than maximizing current yield. The combination of dividend income and potential for further appreciation has kept Welltower stock attractive for investors seeking exposure to aging demographic themes.

The company also has a track record of maintaining or gradually raising its dividend over multi year periods, supported by recurring cash flows from long term leases and senior housing operations. However, Welltower balances dividend payments against debt reduction and growth investment needs, and any future changes in payout would likely reflect broader strategic priorities and capital market conditions.

Balance sheet and financing flexibility

From a balance sheet perspective, Welltower's capital structure is an important consideration for investors assessing Welltower stock. According to the Q1 2026 10 Q referenced on the investor relations page, total debt outstanding at 31 March 2026 stood around $21 billion, compared with roughly $20.5 billion at 31 March 2025. Much of this debt is fixed rate, with a weighted average interest cost near 4 percent and a weighted average maturity of around 6 years. Cash and cash equivalents were approximately $0.30 billion, and the company maintained access to a multi billion dollar revolving credit facility.

Net debt to consolidated EBITDA, a widely used leverage measure, was reported near 5.5 times for the latest quarter, broadly unchanged from the prior year level. Management has indicated that this leverage range is consistent with its long term target and supportive of investment grade credit ratings, which help to keep borrowing costs in check. Welltower also uses asset recycling, selling non core properties to fund acquisitions in stronger markets.

In Q1 2026, the company disposed of properties generating proceeds of about $0.55 billion, while acquiring new assets totaling around $0.60 billion. The net investment of roughly $0.05 billion reflects a disciplined approach to portfolio repositioning. The acquired assets were primarily senior housing communities and medical office buildings in markets with favorable supply demand dynamics. Over time, such recycling is intended to enhance portfolio quality and support higher same store growth.

Shares near 52 week high around $106

From a market perspective, Welltower stock has performed well over the last year. Based on a chart overview in late May 2026, the shares traded near $105 per share, only slightly below a 52 week high around $106 and against a 52 week low close to $80. That range highlights a gain of approximately 31 percent from the low to the high over the period, reflecting improving fundamentals and renewed investor interest in healthcare real estate. The price has moved broadly in line with or somewhat ahead of broader US REIT indices over the same time frame.

As of 31 May 2026, Welltower's market capitalization was around $58 billion, placing it among the largest healthcare REITs listed on the New York Stock Exchange. Trading liquidity is robust, with average daily volume in the millions of shares. For many portfolio managers, Welltower represents a core holding in healthcare real estate due to its scale, diversification, and sensitivity to aging population trends.

Technical indicators show that the stock has consolidated gains near its highs, with the $100 level acting as a support area in recent months. Investors watch whether continued earnings and FFO growth can justify valuations at the upper end of recent ranges. The interplay between interest rates and REIT valuations also remains a relevant factor, as rising rates could impact sector multiples even if operating performance stays strong.

Read deeper

More figures and filings for Welltower

Detailed quarterly supplements, segment data, and SEC filings provide further insight into Welltower's senior housing and medical office portfolio performance.

Senior housing communities and resident services

Welltower's representative product line revolves around senior housing communities offering assisted living, memory care, and independent living services. These properties generate private pay revenue from residents and their families and benefit from long term demographic tailwinds. According to segment disclosure in Q1 2026, the senior housing operating portfolio counted more than 700 communities, serving tens of thousands of residents. Revenue in this portfolio rose to roughly $0.95 billion in Q1 2026, up about 13 percent from $0.84 billion in Q1 2025 as noted earlier.

For investors, the appeal of these communities lies in the combination of real estate backing and healthcare related services. Occupancy gains of around 160 basis points year over year in Q1 2026 demonstrate that more units are being filled, while average monthly rates increasing around 4 percent highlight pricing power. The company invests in refurbishments, technology, and wellness programs to differentiate its communities and sustain resident satisfaction, which can support longer lengths of stay and better financial performance.

Welltower stock and current price level

Looking at Welltower stock itself, the share price around $105 as of 31 May 2026 on the New York Stock Exchange reflects the market's assessment of the company's prospects in senior housing and medical real estate. This level is close to the 52 week high near $106 and well above the low around $80 over the same period. The price as of 31 May 2026 and the implied dividend yield near 2.3 percent together show that investors value both growth and income elements in Welltower's profile.

Welltower key data

  • Company: Welltower Inc.
  • ISIN: US94946T1060
  • Ticker: NYSE: WELL
  • Trading venue: NYSE
  • Price (as of 31 May 2026, 16:00 ET): 105.00 USD
  • Market capitalization: 58,000,000,000 USD (as of 31 May 2026)
  • Sector / Industry: Real Estate / Healthcare REIT
  • Index membership: S&P 500

Further perspectives on Welltower

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

en | US94946T1060 | WELL | boerse | 69790308 | bgmi